The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy

BJU International

Volumn 94, Issue 6, 2004, Pages 812-815

  Winkler, Mathias H ^a,d   Khan, Farooq A ^a   Kulinskaya, Elena ^b   Hoh, Ivan M ^a   McDonald, Donald ^c   Boustead, Gregory ^c   Kaisary, Amir V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c LISTER HOSPITAL   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Adenocarcinoma; Biopsy; Prognosis; Prostate cancer; Stage; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATECTOMY; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 8144222569     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.05038.x     Document Type: Article

References (23)

1. Gibbons RP, Correa RJ Jr, Brannen GE, Weissman RM. Total prostatectomy for clinically localised prostatic cancer: Long term results. J Urol 1989; 171: 564-6
2. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 1997; 277: 1445-51
3. Kattan MW, Eastham JA, Stapleton AMF et al. A pre-operative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998; 90: 766-71
4. Roberts WW, Bergstralh EJ, Blute ML et al. Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 2001; 57: 1033
5. Ravery V, Chastang C, Toublanc M et al. Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol 2001; 37: 449-55
6. Freedland SJ, Csathy GS, Dorey F et al. Percentage prostate needle biopsy tissue with cancer is more predictive than PSA or Gleason score for predicting biochemical failure or adverse pathology following radical prostatectomy. J Urol 2002; 167: 516-20
7. Egawa S, Suyama K, Matsumoto K et al. Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 1998; 52: 433
8. D'Amico AV, Whittington R, Malkowicz SB et al. Clinical utility of the percentage of positive biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 2000; 18: 1164
9. Gohji K, Okamoto M, Takenaka A et al. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men. BJU Int 1999; 83: 39
10. Presti JC, Shinohara K, Bachetti P et al. Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology 1998; 52: 1079
11. Winkler MH, Khan FA, Hoh IM et al. Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: a multicentre audit. BJU Int 2003; 93: 725-9
12. Aleman M, Karakiewicz P, Kupelian P et al. Age and PSA predict likelihood of organ confined disease in men presenting with PSA less than 10 ng/ml: implications for screening. Urology 2003; 62: 70-4
13. D'Amico AV, Whittington R, Malkowicz SB et al. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology 2000; 55: 572-7
14. D'Amico AV, Whittington R, Malkowicz SB et al. Critical analysis of the ability of the endorectal coil magnetic resonance imaging scan to predict pathologic stage, margin status and postoperative prostate-specific antigen failure in patients with clinically organ-confined prostate cancer. J Clin Oncol 1996; 14: 1770-7
15. Yu KK, Scheidler J, Hricak J et al. Prostate cancer. Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 1999; 213: 481-8
16. Cornud F, Flam T, Chauveinc L et al. Extraprostatic spread of clinically localized prostate cancer: Factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 2002; 224: 203-10
17. Wills ML, Sauvageot J, Partin AW et al. Ability of sextant biopsies to predict radical prostatectomy stage. Urology 1998; 51: 759-64
18. Ravery V, Boccon-Gibod LA, Meulemans A et al. Predictive value of pathological features for progression after radical prostatectomy. Eur Urol 1994; 26: 197-201
19. Obek C, Sadek S, Lai S et al. Positive surgical margins with radical retropubic prostatectomy. anatomic site-specific pathologic analysis and impact on prognosis. Urology 1999; 54: 682-8
20. Partin AW, Mangold LA, Lamm DM et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843-8
21. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 1998; 160: 2418-24
22. Man M, Partin AW, Zahurak M et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003; 169: 517-23
23. Freedland SJ, Csathy GS, Dorey F et al. Clinical utility of percentage prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy. Urology 2002; 60: 84-8